Adding Rituxan to treatment may extend survival for lymphoma patients: Study

Long-term treatment with the drug rituximab, or Rituxan, may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news